Related Experiment Video
Updated: Feb 20, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question
Elena Sabini1, Marenza Leo1, Barbara Mazzi1
1Endocrinology Units, Department of Clinical and Experimental Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy.
Graves' orbitopathy (GO) is rarely considered resolved, even after a decade. While some patients report symptom improvement, complete remission based on objective and subjective criteria is uncommon in this chronic condition.
Area of Science:
- Ophthalmology
- Endocrinology
- Autoimmune Diseases
Background:
- Graves' orbitopathy (GO) is often perceived as a chronic condition with lasting effects.
- Understanding the long-term course and potential for remission is crucial for patient management.
Purpose of the Study:
- To investigate the long-term disappearance of Graves' orbitopathy from both patient and physician perspectives.
- To assess the chronic nature of GO over an extended period.
Main Methods:
- A 5-year follow-up study of 99 consecutive patients with a GO history of at least 10 years.
- Ophthalmological examinations and patient self-perception questionnaires were utilized.
Main Results:
- GO resolved based on objective criteria in approximately 8% of patients.
- Subjective resolution was reported by about 24% of patients.
- Only 2% of patients met both objective and subjective criteria for complete GO remission.
Conclusions:
- Graves' orbitopathy is predominantly a chronic disease, with complete resolution being rare even after many years.
- A small subset of patients may experience subjective improvement or objective remission.
- Findings impact patient counseling and management strategies for chronic GO.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Focusing of Light in the Eye

